WOLVERINE ASSET MANAGEMENT LLC - ACHILLION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$380,000
+272.5%
63,091
+652.9%
0.00%
+100.0%
Q4 2014$102,000
+72.9%
8,380
+39.7%
0.00%
+100.0%
Q3 2014$59,000
+78.8%
6,000
+168.1%
0.00%
Q2 2014$33,000
+135.7%
2,238
-1.5%
0.00%
Q1 2014$14,000
-93.0%
2,271
-93.6%
0.00%
-100.0%
Q4 2013$200,000
-57.7%
35,236
-53.2%
0.00%
-63.6%
Q3 2013$473,000
+44.2%
75,238
+100.6%
0.01%
+22.2%
Q2 2013$328,00037,5040.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders